Table 1 CAR-NK cells exhibit obvious advantages compared with CAR-T cells.
From: Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Character | CAR-T | CAR-NK |
|---|---|---|
Risk of GVHD | High | Low |
Anti-cancer effect | High | High |
Risk of Cytokine storm | High | Low |
Cost of product | High | Low |
Source of harvest | Limited | Wide |
Potential of off-the-shelf | Low | High |
